Skip to content
Loading company

Latest annual · FY2022

Millions
Operating income
(125)
Net income
(110)
Free cash flow
(101)

Latest quarter · Q3 FY2023

Millions
Operating income
(26)
Net income
(24)
Free cash flow
(16)
Open Financials

LianBio (LIANY) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Operating income-$125.4 million-$195.6 million10-K 2023-03-28 · proof
Net income-$110.3 million-$196.3 million10-K 2023-03-28 · proof
Cash from operating activities-$99.2 million-$164 million10-K 2023-03-28 · proof
Free cash flow-$101 million-$164.9 million10-K 2023-03-28 · proof
Total assets$320 million$426.3 million-25%10-K 2023-03-28 · proof
Total liabilities$26.3 million$39 million-32.5%10-K 2023-03-28 · proof
Cash and cash equivalents$79.2 million$228.2 million-65.3%10-K 2023-03-28 · proof
What was LianBio (LIANY)'s operating income in fiscal 2022?
LianBio (LIANY) reported operating income of -$125.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$195.6 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was LianBio (LIANY)'s net income in fiscal 2022?
LianBio (LIANY) reported net income of -$110.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$196.3 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was LianBio (LIANY)'s cash from operating activities in fiscal 2022?
LianBio (LIANY) reported cash from operating activities of -$99.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$164 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What was LianBio (LIANY)'s free cash flow in fiscal 2022?
LianBio (LIANY) reported free cash flow of -$101 million for fiscal 2022 (the year ended Dec 31, 2022), against -$164.9 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What are LianBio (LIANY)'s total assets?
As of Dec 31, 2022, LianBio (LIANY) reported total assets of $320 million, against $426.3 million a year earlier (-25%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What are LianBio (LIANY)'s total liabilities?
As of Dec 31, 2022, LianBio (LIANY) reported total liabilities of $26.3 million, against $39 million a year earlier (-32.5%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC
What are LianBio (LIANY)'s cash and cash equivalents?
As of Dec 31, 2022, LianBio (LIANY) reported cash and cash equivalents of $79.2 million, against $228.2 million a year earlier (-65.3%). Source: the 10-K filed with the SEC on Mar 28, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:LIANY&period_type=annual&limit=5"

Information only, not investment advice.